Insulin Resistance: A Potential Risk Factor for Aortic Stenosis

**Aortic stenosis (AS)**, the most common heart valve disease worldwide, might have a newly identified risk factor: **insulin resistance**. Published in the *Annals of Medicine*, the study highlights a potential pathway for prevention. AS causes the narrowing of the aortic valve, making the heart work harder, and can lead to severe complications like heart failure. Its symptoms—chest pain, fatigue, shortness of breath—can take years to manifest, if at all. Insulin resistance, which precedes type 2 diabetes, occurs when cells are unresponsive to insulin, leading to elevated insulin levels. The study analyzed data from 10,144 Finnish men, aged 45 to 73, over a decade. Researchers focused on biomarkers related to insulin resistance, finding significant associations with AS risk, independent of known cardiovascular risk factors. **Fasting insulin, insulin at 30 and 120 minutes, proinsulin, and serum C-peptide** were key markers. Dr. Johanna Kuusisto emphasized managing metabolic health to potentially reduce AS risk. While the study's scope was limited to males, its large cohort and follow-up duration strengthen its conclusions. Further research is needed to explore if improving insulin sensitivity through lifestyle changes can prevent AS.